Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Applied Materials
AMAT
|
+$650M |
| 2 |
Apple
AAPL
|
+$468M |
| 3 |
Marvell Technology
MRVL
|
+$458M |
| 4 |
Chevron
CVX
|
+$410M |
| 5 |
WIX.com
WIX
|
+$392M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$836M |
| 2 |
Bloom Energy
BE
|
+$727M |
| 3 |
Accenture
ACN
|
+$563M |
| 4 |
Broadcom
AVGO
|
+$549M |
| 5 |
Lam Research
LRCX
|
+$543M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.76% |
| 2 | Financials | 11.48% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.37% |
| 5 | Consumer Discretionary | 7.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3401
BioCryst Pharmaceuticals
BCRX
$2.28B
| $814K | ﹤0.01% |
107,192
| – | – |
|
|
VOYG
3402
Voyager Technologies
VOYG
$1.45B
| $812K | ﹤0.01% |
27,271
+757
| +3% | +$26.2K |
|
3403
BlackRock Enhanced Global Dividend Trust
BOE
$673M
| $812K | ﹤0.01% |
70,150
-1,314
| -2% | -$15.1K |
|
3404
Alector
ALEC
$168M
| $811K | ﹤0.01% |
274,042
+259,907
| +1,839% | +$573K |
|
3405
Paysign
PAYS
$501M
| $808K | ﹤0.01% |
128,464
-65,416
| -34% | -$418K |
|
|
LAC
3406
Lithium Americas
LAC
$1.01B
| $802K | ﹤0.01% |
140,388
+33,147
| +31% | +$105K |
|
3407
Kodiak Sciences
KOD
$2.6B
| $800K | ﹤0.01% |
48,853
-217,501
| -82% | -$1.87M |
|
3408
Lifestance Health
LFST
$4B
| $793K | ﹤0.01% |
144,238
+66,074
| +85% | +$324K |
|
|
IBDZ
3409
iShares iBonds Dec 2034 Term Corporate ETF
IBDZ
$866M
| $792K | ﹤0.01% |
29,926
+20,059
| +203% | +$525K |
|
3410
Invesco S&P SmallCap Momentum ETF
XSMO
$3B
| $792K | ﹤0.01% |
10,760
+1,346
| +14% | +$95.1K |
|
3411
Matrix Service
MTRX
$326M
| $791K | ﹤0.01% |
60,482
-52,131
| -46% | -$741K |
|
3412
Medifast
MED
$109M
| $791K | ﹤0.01% |
57,836
-18,965
| -25% | -$265K |
|
3413
Burke & Herbert Financial Services Corp
BHRB
$1.48B
| $790K | ﹤0.01% |
12,802
-6,400
| -33% | -$396K |
|
3414
Wave Life Sciences
WVE
$1.09B
| $790K | ﹤0.01% |
+107,865
| New | +$873K |
|
|
FIVA
3415
Fidelity International Value Factor ETF
FIVA
$587M
| $789K | ﹤0.01% |
+25,210
| New | +$765K |
|
3416
Columbia India Consumer ETF
INCO
$234M
| $788K | ﹤0.01% |
12,184
+225
| +2% | +$14.6K |
|
|
RA
3417
Brookfield Real Assets Income Fund
RA
$708M
| $780K | ﹤0.01% |
58,399
+17,517
| +43% | +$234K |
|
3418
First Trust Europe AlphaDEX Fund
FEP
$526M
| $780K | ﹤0.01% |
+15,233
| New | +$753K |
|
3419
Regional Management Corp
RM
$301M
| $775K | ﹤0.01% |
19,885
-3,545
| -15% | -$133K |
|
|
ACRE
3420
Ares Commercial Real Estate
ACRE
$236M
| $775K | ﹤0.01% |
171,743
-54,400
| -24% | -$253K |
|
3421
AtriCure
ATRC
$1.92B
| $772K | ﹤0.01% |
+21,889
| New | +$754K |
|
3422
Capital Group Global Growth Equity ETF
CGGO
$11.4B
| $769K | ﹤0.01% |
22,493
+13,746
| +157% | +$451K |
|
3423
Lifeway Foods
LWAY
$455M
| $768K | ﹤0.01% |
27,680
-21,104
| -43% | -$594K |
|
3424
Anavex Life Sciences
AVXL
$255M
| $764K | ﹤0.01% |
85,795
-195
| -0.2% | -$1.98K |
|
3425
CareDx
CDNA
$2.26B
| $763K | ﹤0.01% |
52,445
-102,752
| -66% | -$1.46M |
|
Similar funds
Ameriprise's Q3 2025 Portfolio in Review
As of Q3 2025, Ameriprise held 4,210 positions worth $435B, up 7.3% from $406B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Ameriprise's Q3 2025 filing shows 266 new, 1,586 increased, 2,101 reduced and 160 closed positions. Its largest new stake was Aptiv: 3,450,314 shares worth $298M. The largest sale was Microsoft, an estimated $836M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q3 2025 buy was Aptiv: 3,450,314 shares worth $298M.
- Ameriprise added most to Applied Materials in Q3 2025, an estimated $650M increase.
- Ameriprise's biggest Q3 2025 reduction was Microsoft, cutting an estimated $836M.
- Ameriprise fully exited Hess in Q3 2025, selling an estimated $77.2M.
- Ameriprise's ten largest holdings make up 22% of its $435B portfolio in Q3 2025.
- Ameriprise opened 266 new positions and closed 160 in Q3 2025.
- Ameriprise's portfolio value rose 7.3% quarter-over-quarter to $435B.
Based on Ameriprise's 13F filing for Q3 2025, filed 14 Nov 2025.